AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 65 filers reported holding AADI BIOSCIENCE INC in Q2 2024. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,946 | -37.6% | 1,333 | 0.0% | 0.00% | – |
| Q1 2024 | $3,119 | +11.4% | 1,333 | 0.0% | 0.00% | – |
| Q4 2023 | $2,799 | -56.6% | 1,333 | 0.0% | 0.00% | – |
| Q3 2023 | $6,452 | -29.2% | 1,333 | 0.0% | 0.00% | – |
| Q2 2023 | $9,118 | -5.5% | 1,333 | 0.0% | 0.00% | – |
| Q1 2023 | $9,651 | -43.6% | 1,333 | 0.0% | 0.00% | – |
| Q4 2022 | $17,102 | -9.2% | 1,333 | 0.0% | 0.00% | – |
| Q3 2022 | $18,835 | – | 1,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $453,000 | 30.96% |
| ACUTA CAPITAL PARTNERS, LLC | 1,529,402 | $25,954,000 | 12.13% |
| Alerce Investment Management, L.P. | 374,785 | $6,360,000 | 10.77% |
| VR Adviser, LLC | 1,529,402 | $25,954,000 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $8,932,000 | 2.74% |
| RK Capital | 96,100 | $5,356,000 | 1.05% |
| Vivo Capital, LLC | 772,416 | $13,108,000 | 0.90% |
| BVF INC/IL | 879,085 | $14,918,000 | 0.60% |
| Avoro Capital Advisors LLC | 1,829,402 | $31,045,000 | 0.57% |
| Ghost Tree Capital, LLC | 150,000 | $2,546,000 | 0.55% |